Fortrea Holdings FTRE
NASDAQ FTRE
$16.79 -0.27 (-1.58%)
As of: Sep 9, 2026 · 3:59 PM EDT

Fortrea Holdings (FTRE) Cash from Operations Growth (3y) (2025 - 2026)

Analysis

Fortrea Holdings (FTRE) Cash from Operations Growth (3y) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn 11.55%
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn 25.22%
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn 6.66%
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn 11.32%
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn -42.26%
6 Evotec SE 661.34 Mn 235.46 Mn - -
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn 15.56%
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn -42.40%
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn -2.09%
10 VivoSim Labs 1.47 Mn 1.47 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -42.26%
Mar 31, 2026 -104.08%
Dec 31, 2025 76.45%
Sep 30, 2025 2.37%